Physician

Srilatha R Ayirala, M.D.

According to 2025 Medicare claims, Srilatha Ayirala, M.D. (NPI: 1710174867) practices cardiology in the Lawton, OK market, with the plurality of this provider's patient population coming from Comanche, OK. This provider's primary affiliated billing organization is COMANCHE COUNTY HOSPITAL AUTHORITY (NPI: 1003155821; TIN: 736061037) and primary practice location at 73505-6378. Ayirala is affiliated with the Lifecare ACO LLC (ACO ID: A3644), participating under the MSSP model.

Ayirala's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,210 traditional Medicare patients, billed 5,537 HCPCS/CPT codes, and received $157,926 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,933 prescription claims across 460 beneficiaries totaling $460,827 in drug costs, led by Eliquis (Apixaban). 2020 DME data shows 11 claims. Open Payments data shows 16 records totaling $380. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $33,477 to $460,827. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,089	3,244	$136,976
2016	1,854	4,912	$179,267
2017	2,373	6,024	$208,818
2018	2,442	6,383	$227,124
2019	2,591	6,543	$219,651
2020	2,817	6,812	$216,327
2021	2,648	6,700	$219,598
2022	1,990	4,976	$167,227
2023	2,290	5,793	$181,785
2024	2,210	5,537	$157,926

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	113	780	$33,477
2016	183	1,340	$70,393
2017	279	1,821	$114,271
2018	316	1,775	$142,355
2019	326	1,839	$171,418
2020	377	2,267	$248,779
2021	389	2,508	$314,941
2022	390	2,585	$332,635
2023	416	2,768	$396,822
2024	460	2,933	$460,827

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	11	$20,554
2019	N/R	N/R	N/R
2020	N/R	11	$23,768
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	504	676	$64
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	617	633	$47
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	275	306	$47
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	492	507	$8
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	1,266	2,005	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	324	17,216	$322,528
Entresto	Sacubitril/Valsartan	61	3,765	$75,429
Xarelto	Rivaroxaban	18	1,140	$18,913
Metoprolol Succinate	Metoprolol Succinate	356	29,488	$7,827
Losartan Potassium	Losartan Potassium	250	20,418	$3,404

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$380	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Srilatha R. Ayirala, M.D.?

Tedicare shows public-source Medicare data for Srilatha R. Ayirala, M.D. (NPI 1710174867), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Srilatha R. Ayirala, M.D. have ACO affiliation data?

Srilatha R. Ayirala, M.D. is shown with ACO affiliation data for Lifecare ACO LLC (MSSP, ACO ID A3644).

What billing organization is linked to Srilatha R. Ayirala, M.D.?

Srilatha R. Ayirala, M.D. is linked to COMANCHE COUNTY HOSPITAL AUTHORITY (billing NPI 1003155821) in the available physician profile data.

Does Srilatha R. Ayirala, M.D. have Open Payments data?

Srilatha R. Ayirala, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.